"Vertex's Non-Opioid Pain Drug Shows Promise in Late-Stage Trials"
Vertex Pharmaceuticals' experimental non-opioid drug, VX-548, has shown promising results in two Phase III studies, with over 1,000 participants each, by significantly reducing post-surgery pain levels compared to a placebo. The drug's success marks a potential breakthrough in the search for non-addictive pain medication.